Decreased brown adipose tissue thermogenic activity following a reduction in brain serotonin by intraventricular p-chlorophenylalanine.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 2443195)

Published in Biosci Rep on February 01, 1987

Authors

N J Fuller1, D M Stirling, S Dunnett, G P Reynolds, M Ashwell

Author Affiliations

1: MRC Dunn Nutrition Unit, Cambridge.

Articles by these authors

A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message--'keep your waist circumference to less than half your height'. Int J Obes (Lond) (2006) 3.65

Ratio of waist circumference to height may be better indicator of need for weight management. BMJ (1996) 3.17

Ratio of waist circumference to height is strong predictor of intra-abdominal fat. BMJ (1996) 2.58

Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. Br Med J (Clin Res Ed) (1985) 2.45

Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett (1984) 2.36

Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids (2010) 2.19

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10

Attitude of the individual to his own body weight. Br J Prev Soc Med (1974) 2.09

The biogenesis of mitochondria. Annu Rev Biochem (1970) 2.08

Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease. Neurosci Lett (1986) 2.01

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem (1989) 1.94

Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res (1997) 1.56

Human brain dopamine receptors in children and aging adults. Synapse (1987) 1.55

Clozapine-induced hypersalivation and the alpha 2 adrenoceptor. Br J Psychiatry (1995) 1.51

Biochemical markers of calcium and bone metabolism during 18 months of lactation in Gambian women accustomed to a low calcium intake and in those consuming a calcium supplement. J Clin Endocrinol Metab (1998) 1.44

Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J Neurol Neurosurg Psychiatry (1989) 1.41

Deprenyl is metabolized to methamphetamine and amphetamine in man. Br J Clin Pharmacol (1978) 1.35

Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'. Psychopharmacology (Berl) (1978) 1.29

The prevalence of obesity in working populations in London. Proc Nutr Soc (1977) 1.28

Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science (1984) 1.28

Social class, smoking, and obesity. Br Med J (1978) 1.23

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology (1987) 1.20

Neuronal calcium-binding proteins and schizophrenia. Schizophr Res (2002) 1.19

Biogenesis of mitochondria. Fed Proc (1968) 1.17

Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm (Vienna) (2007) 1.14

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol (2007) 1.13

Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett (1983) 1.12

Effect of warm or cold exposure on GDP binding and uncoupling protein in rat brown fat. Am J Physiol (1987) 1.11

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem (1989) 1.11

Measurement by radioimmunoassay of the mitochondrial uncoupling protein from brown adipose tissue of obese (ob/ob) mice and Zucker (fa/fa) rats at different ages. FEBS Lett (1985) 1.08

Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord (1987) 1.06

Effect of calcium supplementation on bone mineral accretion in gambian children accustomed to a low-calcium diet. Am J Clin Nutr (2000) 1.05

Effect of acclimation temperature on the concentration of the mitochondrial 'uncoupling' protein measured by radioimmunoassay in mouse brown adipose tissue. FEBS Lett (1983) 1.05

Proceedings of the Rank Forum on Vitamin D. Br J Nutr (2010) 1.05

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature (1983) 1.04

Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretion. Am J Clin Nutr (1995) 1.02

Prevalance of obesity in a London borough. Practitioner (1974) 1.02

Does phenylethylamine cause schizophrenia? Lancet (1976) 1.02

Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia? Commun Psychopharmacol (1978) 1.02

Adipose tissue: contributions of nature and nurture to the obesity of an obese mutant mouse (ob/ob). Proc R Soc Lond B Biol Sci (1977) 1.01

Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease. Neurosci Lett (1998) 1.00

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. J Neurol Neurosurg Psychiatry (2010) 1.00

Female fat distribution-a simple classification based on two circumference measurements. Int J Obes (1982) 1.00

Vitamin D status and parathyroid hormone concentrations in Chinese women and men from north-east of the People's Republic of China. Eur J Clin Nutr (2000) 0.99

Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport (1996) 0.98

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav Brain Res (2006) 0.98

Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients. J Neurochem (1995) 0.97

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol (2003) 0.96

Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport (1999) 0.95

Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia. Neurosci Lett (1995) 0.95

Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol. Schizophr Res (2004) 0.94

Serotonin concentrations and turnover in brains of depressed suicides. Brain Res (1989) 0.94

Measurement of rat brown-adipose-tissue mitochondrial uncoupling protein by radioimmunoassay: increased concentration after cold acclimation. Biosci Rep (1983) 0.94

Breast-milk IgA and lactoferrin survival in the gastrointestinal tract--a study in rural Gambian children. Acta Paediatr Scand (1989) 0.93

Control of white and brown adipose tissues by the autonomic nervous system. Proc Nutr Soc (1987) 0.93

Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex. J Psychiatr Res (2001) 0.92

Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study. Cell Mol Neurobiol (1992) 0.92

Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. J Neurol Neurosurg Psychiatry (1987) 0.92

Pre-frontal structural and functional deficits associated with individual differences in schizotypal personality. Schizophr Res (1992) 0.92

Human fat cell sizing--a quick, simple method. J Lipid Res (1976) 0.91

Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases. J Neurol Sci (1985) 0.91

Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain. J Psychopharmacol (2008) 0.91

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease. Neurosci Lett (1992) 0.91

Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations. JAMA (1985) 0.91

[3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm (1989) 0.90

Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals (1993) 0.90

Recombinant DNA studies on stored necropsy brain samples from patients with Huntington's chorea. J Clin Pathol (1985) 0.90

Dopamine D2 receptor density remains constant in treated Parkinson's disease. Ann Neurol (1986) 0.90

Obesity: do fat cells from genetically obese mice (C57BL/6J ob/ob) have an innate capacity for increased fat storage? Diabetologia (1978) 0.90

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet (1988) 0.89

Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type. Neurosci Lett (1984) 0.89

Effects of tranylcypromine stereoisomers on monamine oxidation in man. Br J Clin Pharmacol (1980) 0.89

Effect of calcium supplements and stage of lactation on the calcium absorption efficiency of lactating women accustomed to low calcium intakes. Am J Clin Nutr (1995) 0.88

Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration. J Neural Transm (1978) 0.88

Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice. Eur J Neurosci (2010) 0.88

Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J Neural Transm Suppl (2007) 0.88

Vitamin D status does not influence the breast-milk calcium concentration of lactating mothers accustomed to a low calcium intake. Acta Paediatr (1997) 0.88

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. Eur J Pharmacol (1985) 0.88

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm (1989) 0.87

Structural and functional characteristics of the corpus callosum in schizophrenics, psychiatric controls, and normal controls. A magnetic resonance imaging and neuropsychological evaluation. Arch Gen Psychiatry (1990) 0.87

Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases. J Neural Transm Suppl (2006) 0.86

Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders. Behav Brain Res (1996) 0.86

Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol (1995) 0.85

Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease. Neurosci Lett (1986) 0.85

Is genetically transmitted obesity due to an adipose tissue defect? Proc R Soc Lond B Biol Sci (1979) 0.85

Raised urinary secretory IgA in chronic diarrhoea. Arch Dis Child (1991) 0.85

Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes. Arch Gen Psychiatry (1987) 0.85

Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain. Neurosci Lett (1987) 0.85

Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci Lett (2001) 0.84

An evaluation of structural and functional prefrontal deficits in schizophrenia: MRI and neuropsychological measures. Psychiatry Res (1992) 0.84

Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Neuroscience (1988) 0.84

Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease. Neuropharmacology (1988) 0.84

Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs. J Psychopharmacol (2006) 0.84

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int Clin Psychopharmacol (1993) 0.84

Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia. Neurosci Lett (2001) 0.84

An investigation of ethnic differences in bone mineral, hip axis length, calcium metabolism and bone turnover between West African and Caucasian adults living in the United Kingdom. Ann Hum Biol (1999) 0.84